• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Why The Future of Lateral Flow Testing is Digital

by Christa Schnider, Business Development Director, Jabil Healthcare 12/28/2022 Leave a Comment

Why The Future of Lateral Flow Testing is Digital

Lateral flow immunoassay tests (or LFTs, for short) have been in use for decades, becoming an indispensable tool within diagnostics’ (Dx) practice, as well as a growing range of applications outside healthcare. LFT's capacity for delivering fast turnaround—rapid detection in less than 20 minutes—from sample to result has made LFTs central to the shift moving triage and primary care closer to the patient at point-of-care (POC) and point-of-need (PON).  Being intuitive for the user,
Read More

Biomica Raises $20M to Advance its Pipeline of Microbiome-based Therapeutics

by Jasmine Pennic 12/21/2022 Leave a Comment

Biomica Raises $20M to Advance its Pipeline of Microbiome-based Therapeutics

What You Should Know: - Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd raises $20M led by Shanghai Healthcare Capital (SHC). - The financing round will enable Biomica to forge ahead, developing its pipeline of microbiome-based therapeutics. Biomica plans to use the proceeds to complete its current BMC128 phase 1 immuno-oncology study and advance to phase 2 clinical trial; scale up and complete GMP
Read More

4 Key Benefits of the Medical Call Center in the Post-COVID-19 Era

by Brian Briggs, VP of Call Center Operations, Stericycle Communication Solutions (Acquired by Carenet Health) 12/20/2022 Leave a Comment

4 Key Benefits of the Medical Call Center in the Post-COVID-19 Era

In today’s digital-first world, the medical call center still plays a crucial role in connecting healthcare consumers with providers. As an important method of alleviating staffing shortages, elevating the patient experience, and optimizing revenue for healthcare organizations, strategic call center programs covered unique gaps in the patient journey during the early days of the COVID-19 pandemic such as information hotlines and patient outreach to engage patients once the facility re-opened. In
Read More

Pangea Biomed Adds $5M for its Multi-Cancer Response Predictor

by Syed Hamza Sohail 12/15/2022 Leave a Comment

Pangea Biomed Adds $5M for its Multi-Cancer Response Predictor

What You Should Know: - Pangea Biomed, the biotech company behind ENLIGHT, the multi-cancer response predictor improving the effectiveness of precision oncology, announced $5M in additional funding reaching a total seed round of $12M. - The latest fundraising is led by angel investor Danny Tocatly and existing investor NFX, and will be used to expand US operations, drive commercial partnerships, and scale product offerings. Expanding US Operations and Fostering Commercial
Read More

Sameday Health Launches Single Swab Test for COVID-19, Flu, and RSV

by Jasmine Pennic 12/15/2022 Leave a Comment

Sameday Health Launches Single Swab Test for COVID-19, Flu, and RSV

What You Should Know: - Sameday Health, a nationwide testing and wellness provider, today announced the launch of its single swab test for COVID-19, influenza A/B strains, and respiratory syncytial virus (RSV). - The swab test is currently offered in Los Angeles clinics with plans to soon expand statewide — delivers reliable results, unmatched efficiency, and peace of mind amid the "tripledemic." - The new testing service utilizes laboratory-developed nasal
Read More

Convenient Scapegoat: Why Hesitancy is Not the Cause of Low Vaccination Rates in Africa

by Dr. Ernest Darkoh-Ampem, co-founder of BroadReach Group 12/15/2022 Leave a Comment

Convenient Scapegoat: Why Hesitancy is Not the Cause of Low Vaccination Rates in Africa

At this year’s World Economic Forum in Davos, the topic of the COVID-19 pandemic and its destructive impact was central to many of the discussions that took place. Among them, was the issue of vaccine hesitancy around the world, especially in underdeveloped nations such as those in Africa. According to Africa CDC, as of September 2022, Africa, the second most-populated continent, has only vaccinated 21% of its people; an inadequate number In comparison to other populated countries such as India
Read More

When Innovation Isn’t Enough: Pharma’s Next Frontier

by Michael Sheeley, Co-founder & CEO of Nurse-1-1 12/14/2022 Leave a Comment

Michael Sheeley, Co-founder & CEO of Nurse-1-1

I met Mark Cuban once. Our conversation didn’t last very long. It was at a medical conference a few years ago. Cuban felt like a great guy to approach with an idea for a healthcare startup. We were both investors in an automation software startup called Zoba, and I of course knew him from his role on the popular entrepreneurial reality TV series Shark Tank. A few seconds into our conversation, Cuban paused. “Healthcare is hard,” he sighed. That was his way of politely telling me: for that
Read More

AI/ML Used for Clinical Trial-Site Identification Simultaneously Improves Enrollment Rates and Diversity

by Lucas Glass, VP of the Analytics Center of Excellence (ACOE), IQVIA 12/12/2022 Leave a Comment

AI/ML Used for Clinical Trial-Site Identification Simultaneously Improves Enrollment Rates and Diversity

Ethnic and racial minorities are commonly underrepresented in clinical trials. This problem is so severe that in April, the U.S. Food and Drug Administration (FDA) expanded upon existing guidance to further emphasize recommendations to sponsors developing treatments to increase enrollment from underrepresented populations in the U.S., including African-American, Hispanic, Asian and other persons of color, in clinical trials. In the updated guidance, the FDA provided details on what sponsors
Read More

Vevo Launches with $12M to Scale Vivo Data Generation to Discover Better Drugs

by Fred Pennic 12/08/2022 Leave a Comment

Vevo Launches with $12M to Scale Vivo Data Generation to Discover Better Drugs

What You Should Know: - Vevo Therapeutics, an SF-based biotechnology company, launched today with a $12M seed round led by General Catalyst and Wing Venture Capital using its Mosaic in vivo drug discovery platform and next-generation AI models to uncover better drugs for more patients. - Vevo is the first platform to make in vivo data generation scalable with single-cell precision + will create the world’s largest atlas of how drugs interact with patient cells. In a single in vivo
Read More

Aetion, FDA to Evaluate Real-World Data Standardization for COVID-19

by Fred Pennic 12/07/2022 Leave a Comment

Aetion, FDA to Evaluate Real-World Data Standardization for COVID-19

What You Should Know: - Aetion, a provider of real-world evidence (RWE) technology and analytics, today announced that the FDA has extended Aetion’s contract to evaluate real-world data (RWD) involving COVID-19 medical countermeasures. - Aetion will be expanding its work to evaluate data standardization in the context of COVID-19. Aetion has been collaborating with FDA since May 2020, providing validated software platform capabilities and RWD/E expertise to contribute to rapid evidence
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 46
  • Go to page 47
  • Go to page 48
  • Go to page 49
  • Go to page 50
  • Interim pages omitted …
  • Go to page 86
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |